Protein kinase C-θ is an early survival factor required for differentiation of effector CD8+ T cells

被引:54
作者
Barouch-Bentov, R
Lemmens, EE
Hu, JR
Janssen, EM
Droin, NM
Song, JX
Schoenberger, SP
Altman, A
机构
[1] La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA
[2] La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA
[3] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.175.8.5126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
CD8(+) T cells are crucial for host defense against invading pathogens and malignancies. However, relatively little is known about intracellular signaling events that control the genetic program of their activation and differentiation. Using CD8+ T cells from TCR-transgenic mice crossed to protein kinase C-theta (PKC theta)-deficient mice, we report that PKC theta is not required for Ag-induced CD8(+) T cell proliferation, but is important for T cell survival and. differentiation into functional, cytokine-producing CTLs. Ag-stimulated PKC theta(-/-) T cells underwent accelerated apoptosis associated with deregulated expression of Bcl-2 family proteins and displayed reduced activation of ERKs and JNKs. Some defects in the function of PKC theta(-/-) T cells (poor survival and reduced Bcl-2 and Bcl-x(L) expression, CTL activity, and IFN-gamma expression) were partially or fully restored by coculture with wild-type T cells or by addition of exopnous IL-2, whereas others (increased Bim(EL) expression and TNF-alpha production) were not. These findings indicate that PKC theta, although not essential for initial Ag-induced proliferation, nevertheless plays an important role in promoting and extending T cell survival, thereby enabling the complete genetic program of effector CD8(+) differentiation. The requirement for PKC theta in different types of T cell-dependent responses may, therefore, depend on the overall strength of signaling by the TCR and costimulatory receptors and may reflect, in addition to its previously established role in activation, an important, hitherto unappreciated, role in T cell survival.
引用
收藏
页码:5126 / 5134
页数:9
相关论文
共 42 条
[1]
Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death [J].
Akbar, AN ;
Salmon, M .
IMMUNOLOGY TODAY, 1997, 18 (02) :72-76
[2]
c-Jun NH2-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8+ T cell-mediated antiviral immunity [J].
Arbour, N ;
Naniche, D ;
Homann, D ;
Davis, RJ ;
Flavell, RA ;
Oldstone, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) :801-810
[3]
Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO
[4]
2-K
[5]
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[6]
Induction of a CD8(+) cytotoxic T lymphocyte response by cross-priming requires cognate CD4(+) T cell help [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Miller, JFAP ;
Heath, WR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :65-70
[7]
PKCθ signals activation versus tolerance in vivo [J].
Berg-Brown, NN ;
Gronski, MA ;
Jones, RG ;
Elford, AK ;
Deenick, EK ;
Odermatt, B ;
Littman, DR ;
Ohashi, PS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06) :743-752
[8]
Protein kinase C θ and ε promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD [J].
Bertolotto, C ;
Maulon, L ;
Filippa, N ;
Baier, G ;
Auberger, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :37246-37250
[9]
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo [J].
Blattman, JN ;
Grayson, JM ;
Wherry, EJ ;
Kaech, SM ;
Smith, KA ;
Ahmed, R .
NATURE MEDICINE, 2003, 9 (05) :540-547
[10]
CD8+ T cell responses:: it's all downhill after their prime ... [J].
Blattman, JN ;
Cheng, LE ;
Greenberg, PD .
NATURE IMMUNOLOGY, 2002, 3 (07) :601-602